{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"1.71","upperLimit":"41.89","value":"18.30"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"57"}],"units":"Participants"}],"description":"Time to relapse (treatment failure) is measured in months and calculated as (Date of first surgery - Date of first relapse after surgery + 1)/(365.25/12). Time to relapse will be censored at the date of the last visit or start date of further anti-tumor therapy or intervention, whichever comes first.","dispersionType":"Full Range","groups":[{"description":"pemetrexed: 500 mg/m2, intravenous, every 21 days x 4 cycles cisplatin: 75 mg/m2, intravenous, every 21 days x 4 cycles chemotherapy, surgery then chest radiation x 54 gray (Gy)","id":"OG000","title":"Pemetrexed"}],"paramType":"MEAN","populationDescription":"All participants who had undergone surgery.","reportingStatus":"POSTED","timeFrame":"baseline to stopping treatment","title":"Time to Treatment Failure","type":"SECONDARY","unitOfMeasure":"months"}